Bioadaptives (BDPT) Equity Ratio (2019 - 2025)
Historic Equity Ratio for Bioadaptives (BDPT) over the last 7 years, with Q3 2025 value amounting to 11.78.
- Bioadaptives' Equity Ratio rose 6972.34% to 11.78 in Q3 2025 from the same period last year, while for Sep 2025 it was 11.78, marking a year-over-year increase of 6972.34%. This contributed to the annual value of 5.59 for FY2024, which is 6469.51% up from last year.
- According to the latest figures from Q3 2025, Bioadaptives' Equity Ratio is 11.78, which was up 6972.34% from 4.17 recorded in Q2 2025.
- Over the past 5 years, Bioadaptives' Equity Ratio peaked at 3.48 during Q3 2023, and registered a low of 220.0 during Q2 2024.
- Moreover, its 5-year median value for Equity Ratio was 15.83 (2023), whereas its average is 35.13.
- Per our database at Business Quant, Bioadaptives' Equity Ratio tumbled by 101835.31% in 2024 and then surged by 9810.64% in 2025.
- Quarter analysis of 5 years shows Bioadaptives' Equity Ratio stood at 7.36 in 2021, then tumbled by 428.79% to 38.9 in 2022, then skyrocketed by 59.3% to 15.83 in 2023, then skyrocketed by 64.7% to 5.59 in 2024, then plummeted by 110.77% to 11.78 in 2025.
- Its Equity Ratio was 11.78 in Q3 2025, compared to 4.17 in Q2 2025 and 14.22 in Q1 2025.